Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Treasury Shares (2021)

Historic Treasury Shares for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q4 2021 value amounting to $247165.0.

  • Coeptis Therapeutics Holdings' Treasury Shares changed N/A to $247165.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $247165.0, marking a year-over-year change of. This contributed to the annual value of $247165.0 for FY2021, which is N/A changed from last year.
  • As of Q4 2021, Coeptis Therapeutics Holdings' Treasury Shares stood at $247165.0.
  • Coeptis Therapeutics Holdings' 5-year Treasury Shares high stood at $247165.0 for Q4 2021, and its period low was $247165.0 during Q4 2021.